YHM-17980-10738
3 vaccinations
2 coded responses
40 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 955 / CA
- Registered
- 2021-01-31
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Registered dependents
4QA-28460-83368
Child or adolescent in my care · Male · 2022-07-09
TJ8-11371-83635
Child or adolescent in my care · Male · 2022-07-09
JCP-27953-89390
Child or adolescent in my care · Female · 2023-03-29
Timeline
-
2021-01-29
Dose 1 — Moderna
-
2021-01-31
Registered in v-safe
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-02-26
-
2021-03-01
Dose 2 — Moderna
- 2021-03-01
-
2021-03-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-05-31
-
2021-08-30
Survey response — 6 months, dose 2MedDRA: Gastrooesophageal reflux disease, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: GERD and allergiesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-30
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-09-01
-
2021-10-28
Dose 3 — Moderna
- 2021-10-28
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-25
-
2021-12-02
Survey response — day 35, dose 3MedDRA: Menstruation irregular, Reaction to previous exposure to any vaccine — Feeling: GoodFree text: Menstrual irregularities same as I experienced after the second shot. Not super concerned because it cleared up last time and there was no pain associated, but I think it is helpful for women to know what to expect as possible side effects.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-09
- 2022-01-27
- 2022-04-28
- 2022-10-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Moderna | |
| 2 | 2021-03-01 | Moderna | |
| 3 | 2021-10-28 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-30 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Symptoms: GERD and allergies
Release 10 — day 35, dose 3
Symptoms: Menstrual irregularities same as I experienced after the second shot. Not super concerned because it cleared up last time and there was no pain associated, but I think it is helpful for women to know what to expect as possible side effects.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastrooesophageal reflux disease | ✓ | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Reaction to previous exposure to any vaccine | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release